• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Sunday, July 5, 2026
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

Make In India: Why you should invest in ‘Biotechnology Sector’ in India ?  

by
April 26, 2015
in Business
Reading Time: 3 mins read
0
Make In India: Why you should invest in ‘Biotechnology Sector’ in India ?  
TwitterWhatsappLinkedin

biotech

You might also like

UK Culture Secretary Lisa Nandy Quits X, Calls Platform a Threat to Healthy Public Debate

OpenAI Plans Sharp AI Price Cuts As Anthropic Rivalry Heats Up Ahead Of Both Companies’ IPOs

Microsoft Launches Frontier Company With 6,000 Engineers And $2.5 Billion To Fix Enterprise AI Adoption Problem

India is home to one-seventh of the world’s population, i.e. approximately 1.2 billion people. This huge population of the country saw a laudable dream of India becoming the ‘manufacturing hub’ of the world  after Prime Minister Narendra Modi launched his ‘Make in India’ campaign. Achieving this vision is not going to be an easy task but sooner later we will get there. The good thing is that the country has already started taking its baby steps towards making this dream come true.

In recent developments, emergence of India as partner country at HANNOVER MESSE -The world’s biggest industrial fair,shows that continuous efforts are being made in crafting India as a Manufacturing Hub. A major attraction at the fair was ‘India on the threshold of becoming the next global biotech hub’.

India already has many of the necessary ingredients such as a talented and enthusiastic scientific workforce, equipments and infrastructure needed in order to grow its bio-economy. This industry can provide significant economic growth and development to the people of India and around the world and has the potential to become the jewel of the Indian economy. It has the capacity to address the substantial healthcare, food, energy, environmental and other critical issues of the country.

The Indian biotechnology sector is divided into five major segments — bio-pharma, bio-services, bio-agriculture, bio-industrial and bio-informatics. Besides, India’s biotech industry is the third largest in Asia-Pacific region and is on the cusp of entering a new era.

This has been possible due to increase in investments, outsourcing activities, exports and the government’s focus on the sector. Also, the country is able to produce a strong pool of scientists and engineers who are capable of developing cost-effective manufacturing capabilities. Moreover, concrete steps taken towards setting up of national research laboratories, centers of academic excellence and several other institutes in medical science , educational and training institutes offering degrees and diplomas in biotechnology, bio-informatics and biological sciences have given a boost to sector.

As per the statistics (from Make in India site), the sector’s market size is expected to go up to USD 11.6 Billion by 2017. This will take place due to a range of factors such as growing demand for healthcare services, intensive R&D activities and strong government initiatives, fast-developing clinical capabilities with the country becoming a popular destination for global companies for clinical trials, contract research and manufacturing activities. Furthermore, The Indian biotech industry is expected to grow at an average growth rate of around 30% a year and touch USD 100 Billion by 2025.

The biotech industry in India is being watched by ‘The Department of Biotechnology, Ministry of Science & Technology, Government of India’ and ‘The Association of Biotechnology Led Enterprises’ which are two major agencies in India in biotech segment. The Department of Biotechnology has established Operational biotech parks in various parts of the country including at Lucknow in Uttar Pradesh, Bangalore in Karnataka, Kalamassery and Kochi in Kerala, Guwahati in Assam and Chindwara in Madhya Pradesh to facilitate product development, R&D, and the development of biotechnology industrial sector.

Additionally, investments by global companies such as Limagrain (France), Endo Pharmaceuticals (USA), Sanofi Aventis (France) in pharmaceuticals are permitted up to 100% by Foreign Direct Investment (FDI) policy.

All these factors come together to reinforce each other and produce a solid ground which represents new business potential in India in biotech sector. The industry is in the phase of witnessing huge growth in terms of revenue and is heading on an evident path to success. So, if you are looking forward to invest without associating much risk to your investment then the industry is more than eager to receive your attention. The land is filled with opportunities to become a major player in the biotechnology sector across the world!

 

 

 

 

Tags: BioTech
Tweet54SendShare15
Previous Post

Micromax looks for strategic investors to diversify portfolio

Next Post

Smartphones still remain ‘too expensive for many’ in India

Recommended For You

UK Culture Secretary Lisa Nandy Quits X, Calls Platform a Threat to Healthy Public Debate

by Ishaan Negi
July 5, 2026
0
UK Culture Secretary Lisa Nandy Quits X, Calls Platform a Threat to Healthy Public Debate

The debate over social media's role in modern society has taken another dramatic turn. UK Culture Secretary Lisa Nandy has announced that she is leaving X (formerly Twitter),...

Read more

OpenAI Plans Sharp AI Price Cuts As Anthropic Rivalry Heats Up Ahead Of Both Companies’ IPOs

by Rounak Majumdar
July 4, 2026
0
OpenAI Plans Sharp AI Price Cuts As Anthropic Rivalry Heats Up Ahead Of Both Companies' IPOs

The AI industry's two most famous rivals are on the verge of a pricing war that could change the sector's economics, just as both companies prepare to go...

Read more

Microsoft Launches Frontier Company With 6,000 Engineers And $2.5 Billion To Fix Enterprise AI Adoption Problem

by Rounak Majumdar
July 4, 2026
0
Microsoft Launches Frontier Company With 6,000 Engineers And $2.5 Billion To Fix Enterprise AI Adoption Problem

Microsoft has made its most aggressive move yet to turn AI investment into measurable enterprise outcomes. On July 2, 2026, the company unveiled Microsoft Frontier Co., a new...

Read more
Next Post
Smartphones still remain ‘too expensive for many’ in India

Smartphones still remain 'too expensive for many' in India

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at info@techstory.in

Advertise With Us

Reach out at - info@techstory.in

Aviator Game India 2026

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple Artificial Intelligence bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News OpenAI samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2025 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2025 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?